Results 81 to 90 of about 2,002,341 (191)
AAPM MEDICAL PHYSICS PRACTICE GUIDELINE 10.b: Scope of practice for clinical medical physics
Journal of Applied Clinical Medical Physics, Volume 26, Issue 11, November 2025.Abstract The American Association of Physicists in Medicine (AAPM) is a nonprofit professional society whose mission is “Advancing medicine through excellence in the science, education and professional practice of medical physics.” The AAPM has roughly 10,000 members and is the principal organization of medical physicists in the United States. The AAPM
Seng Boh Lim +8 more
wiley +1 more source
MVP-Assisted Temporary Vascular Occlusion during 90Y Radioembolization: A Case Report
Journal of Clinical Interventional Radiology ISVIRYttrium-90 radioembolization is an effective treatment for liver cancers. However, deposition of radioactive microspheres in nondiseased liver can result in parenchymal injury.
John J. Park +2 more
doaj +1 more source
International Journal of Hepatology, 2013 Portal vein tumor thrombosis (PVTT) is a common complication of hepatocellular carcinoma (HCC) and has a negative impact on prognosis. This characteristic feature led to the rationale of the present trial designed to assess the efficacy and the safety of
M. Pracht +10 more
doaj +1 more source
Liver‐directed therapies for colorectal liver metastases
Cancer, Volume 131, Issue 20, 15 October 2025.Abstract Colorectal cancer is the third most common cancer diagnosed in the United States, with an anticipated 53,000 deaths from this disease in 2025. Greater than one in five patients will present with synchronous colorectal liver metastases (CRLMs), and 25%–30% will develop CRLMs during the course of the disease.
Andrew D. Folkerts +2 more
wiley +1 more source
Cancer Innovation, Volume 4, Issue 5, October 2025.Therapeutic protocols are urgent for liver metastases in Gastrointestinal stromal tumors (GIST) patients. This article presents China's first case in GIST liver metastases patients, treating with Yttrium‐90 resin microsphere selective internal radiation therapy, reviews management challenges, and highlights the emerging role of novel therapies to ...
Li Xing +4 more
wiley +1 more source
Frontiers in Oncology, 2013 Purpose: Ytrrium-90 radioembolization (RE) is a locoregional therapy option for hepatocellular carcinoma (HCC). Sorafenib is a multikinase inhibitor used in HCC that can potentially affect the efficacy of RE by altering tumor vascularity or suppressing ...
Nitesh eRana +6 more
doaj +1 more source
Radioembolization in the Treatment of Neuroendocrine Tumor Metastases to the Liver
International Journal of Hepatology, 2011 Surgical excision remains the preferred treatment for resectable hepatic metastases of neuroendocrine tumors. In cases of more disseminated hepatic disease, transarterial radioembolization with Yttrium-90- (90Y-) labeled microspheres has been ...
Martin Vyleta, Douglas Coldwell
doaj +1 more source
Successful Yttrium-90 Microsphere Radioembolization for Hepatic Metastases of Prostate Cancer
Case Reports in Oncology, 2017 Prostate cancer is the most common solid tumor malignancy worldwide with an estimated 180,000 new cases of prostate cancer and 26,000 deaths in the USA in 2016.
Alexander C. Bunck +8 more
doaj +1 more source
Radiation gastritis after Yttrium-90 radioembolization [PDF]
Gastrointestinal Endoscopy, 2018 Shana, Kothari +3 more
openaire +2 more sources
Tuning Your RADIOembolization: Imaging-guidance of Yttrium-90 Radioembolization
, 2016 Hepatocellular carcinoma (HCC) is the second leading cause of cancer death in the world and the liver is a common site of metastases from other primary neoplasms. Many patients are not surgical candidates.
Gordon, Andrew Christian
core